Brynn K Dredla1, Pablo R Castillo2. 1. Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA. Dredla.brynn@mayo.edu. 2. Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL, 32224, USA.
Abstract
PURPOSE OF REVIEW: To review the clinical evidence for a relationship between obstructive sleep apnea and hypertension, arrhythmias, coronary artery disease, and congestive heart failure. RECENT FINDINGS: Current data show that obstructive sleep apnea is a risk for cardiovascular disease. Studies have linked untreated moderate to severe obstructive sleep apnea to hypertension, cardiac arrhythmias, coronary artery disease, and congestive heart failure. However, uncertainty regarding benefits of treatment of obstructive sleep apnea to reduce the risk of cardiovascular disease still exists. The issue of poor compliance has been an on-going limitation of CPAP trials. Evidence shows obstructive sleep apnea is a risk factor for cardiovascular disease but trials have yet to clarify if cardiovascular disease morbidity and mortality decreases with treatment of the apnea. Future treatment trials are needed to address the question of whether treatment decreases cardiovascular risk in patients with obstructive sleep apnea.
PURPOSE OF REVIEW: To review the clinical evidence for a relationship between obstructive sleep apnea and hypertension, arrhythmias, coronary artery disease, and congestive heart failure. RECENT FINDINGS: Current data show that obstructive sleep apnea is a risk for cardiovascular disease. Studies have linked untreated moderate to severe obstructive sleep apnea to hypertension, cardiac arrhythmias, coronary artery disease, and congestive heart failure. However, uncertainty regarding benefits of treatment of obstructive sleep apnea to reduce the risk of cardiovascular disease still exists. The issue of poor compliance has been an on-going limitation of CPAP trials. Evidence shows obstructive sleep apnea is a risk factor for cardiovascular disease but trials have yet to clarify if cardiovascular disease morbidity and mortality decreases with treatment of the apnea. Future treatment trials are needed to address the question of whether treatment decreases cardiovascular risk in patients with obstructive sleep apnea.
Authors: Richard B Berry; Rita Brooks; Charlene Gamaldo; Susan M Harding; Robin M Lloyd; Stuart F Quan; Matthew T Troester; Bradley V Vaughn Journal: J Clin Sleep Med Date: 2017-05-15 Impact factor: 4.062
Authors: Cristiano Fava; Stefania Dorigoni; Francesco Dalle Vedove; Elisa Danese; Martina Montagnana; Gian Cesare Guidi; Krzysztof Narkiewicz; Pietro Minuz Journal: Chest Date: 2014-04 Impact factor: 9.410
Authors: Apoor S Gami; Gregg Pressman; Sean M Caples; Ravi Kanagala; Joseph J Gard; Diane E Davison; Joseph F Malouf; Naser M Ammash; Paul A Friedman; Virend K Somers Journal: Circulation Date: 2004-07-12 Impact factor: 29.690
Authors: Rupa Lakshmi Iyengar-Kapuganti; Cynara S Maceda; Lori B Croft; Simonette T Sawit; Laura E Crowley; Mark Woodward; Mary Ann McLaughlin Journal: BMJ Open Date: 2022-04-19 Impact factor: 3.006